The city of Birmingham, Alabama, currently has 1 active clinical trials seeking participants for Hepatitis C research studies.
Rapid HCV Treatment Access for Persons Who Use Drugs
Recruiting
This study is being done to compare two strategies to deliver HCV treatment to persons with hepatitis C virus (HCV) who also use drugs and are participating in an outpatient opioid treatment program (OTP). Participants will be randomized into one of two treatment groups: Test and treat plus peer-mentors: This treatment group will be offered 8 weeks of glecaprevir/pibrentasvir (an FDA approved HCV treatment) within days of HCV diagnosis at the OTP. Participants in this group will receive treatme... Read More
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
11/08/2023
Locations: University of Alabama, Birmingham, Alabama
Conditions: Hepatitis C Virus Infection, Response to Therapy of